A system and method for determining a health outcome, comprising: receiving first and second images or videos of a wound of a patient; comparing the images or videos to detect a characteristic of the wound, the characteristic including an identification of a change in the wound; receiving at least one non-image or non-video data input that includes data about the patient; executing a machine learning algorithm comprising a dataset of images or videos to analyze the identified change in the wound and to correlate at least one first image or video and at least one second image or video with the at least one non-image or non-video data input and to train the machine learning algorithm with the identification of a change in the wound; and generating a medical outcome prediction regarding a status and recovery of the patient in response to correlating the at least one additional input with the first and second images or videos.

Systems, devices, and technical methods of the present disclosure leverage digital visitor logs from confinement facilities to identify people of interest that may be involved in incidents to which first responders are dispatched. When a phone call is received at phone public safety access point, a first query including a name associated with the call is transmitted to a digital visitor log for a confinement facility. A digital response to the first query identifies a visitee who was visited by a visitor by that name while the visitee was in confinement. The visitee's name is then transmitted in a second query to a digital repository containing release records; a digital response indicates the visitee was released before the call was received. An electronic notification that identifies the visitee is transmitted to a device associated with an agent who is responding to the call.

A scheme for securely transferring a patient data file to an intended recipient regardless of a transfer mode selected by a sender. Encryption system executing at the sender device is operative to encrypt each plaintext data line of a file, one by one, using a symmetric key and a starting IV that is incremented per each line, resulting in corresponding ciphertext lines added to an encrypted file. A hash is generated based on the encrypted file. An encrypted header containing the symmetric key, starting IV and the hash is generated using a public key of the recipient, which is appended to the encrypted file. The encrypted header and associated encrypted file are transmitted to the recipient in any manner. Upon receipt, the recipient decrypts the encrypted header using a private key to obtain the symmetric key, starting IV and the hash, which are used by the recipient to validate and decrypt the encrypted file on a line-by-line basis.

A device agent including an information accessor for accessing association information obtained via an information reader. The association information includes medical device information for uniquely identifying the medical device, and device agent information for facilitating in an association between the medical device and the information reader. The device agent also includes an associator for associating the medical device and the information reader based on the association information.

A device agent including an information accessor for accessing association information obtained via an information reader. The association information includes medical device information for uniquely identifying the medical device, and device agent information for facilitating in an association between the medical device and the information reader. The device agent also includes an associator for associating the medical device and the information reader based on the association information.

Methods and apparatuses for automatically identifying therapeutically equivalent alternative medications for reducing patient costs. These methods and apparatuses may interface with a patient's electronic health records and Payer databases and identify alternative medications that offer cost savings to the patient and Payer. The methods and apparatuses described herein may also incentivize patients to select cost-saving medication alternatives.

Methods and apparatuses for automatically identifying therapeutically equivalent alternative medications for reducing patient costs. These methods and apparatuses may interface with a patient's electronic health records and Payer databases and identify alternative medications that offer cost savings to the patient and Payer. The methods and apparatuses described herein may also incentivize patients to select cost-saving medication alternatives.

Methods, apparatuses, and systems are disclosed for analyzing quality control (QC) strategies that are applied to testing processes an analyte in order to meet an acceptable level of probability of patient harm that could result from incorrect test results. The measure of patient harm takes into account severity of patient harm, as well as its occurrence. Methods include calculating, based on the parameters of the QC strategies and the test apparatus, an expected number of incorrect final results E(N.sub.uf) due to a test system failure. The value of E(N.sub.uf) can be used as part of a calculation of a predicted level of probability patient harm. The ratio of the acceptable level of probability of patient harm to the predicted level of probability patient harm can determine the adequacy of the QC strategies.

Methods, apparatuses, and systems are disclosed for analyzing quality control (QC) strategies that are applied to testing processes an analyte in order to meet an acceptable level of probability of patient harm that could result from incorrect test results. The measure of patient harm takes into account severity of patient harm, as well as its occurrence. Methods include calculating, based on the parameters of the QC strategies and the test apparatus, an expected number of incorrect final results E(N.sub.uf) due to a test system failure. The value of E(N.sub.uf) can be used as part of a calculation of a predicted level of probability patient harm. The ratio of the acceptable level of probability of patient harm to the predicted level of probability patient harm can determine the adequacy of the QC strategies.

Embodiments are generally directed to systems and apparatuses for tracking usage of an item. For example, an apparatus may be provided for tracking use of a packetized item. The apparatus may include a microprocessor, a power source, and a structural layer to which the microprocessor and power source are coupled. The structural layer may include a container that is configured to hold various items. The container may also include an opening that allows access to the items. The apparatus may further include a cover layer that is configured to cover the opening of the container. The cover layer may include at least one bendable sensor placed over the opening of the container. The microprocessor may be configured to determine, using detected movements in the bendable sensor, whether the container has been opened.